<i>STAT3</i> mutation impacts biological and clinical features of T-LGL leukemia.

导出 OA

翻译打印收藏纠错

作者： Antonella,Teramo ^[1] ; Gregorio,Barilà ^[2] ; Giulia,Calabretto ^[1] ; Chiara,Ercolin ^[2] ; Thierry,Lamy ^[1] ; Aline,Moignet ^[2] ; Mikael,Roussel ^[1] ; Cédric,Pastoret ^[2] ; Matteo,Leoncin ^[3] ; Cristina,Gattazzo ^[3] ; Anna,Cabrelle ^[4] ; Elisa,Boscaro ^[4] ; Sara,Teolato ^[1] ; Elisa,Pagnin ^[1] ; Tamara,Berno ^[2] ; Elena,De March ^[2] ; Monica,Facco ^[1] ; Francesco,Piazza ^[1] ; Livio,Trentin ^[1] ; Gianpietro,Semenzato ^[1] ; Renato,Zambello ^[1]

作者单位： Padua University School of Medicine, Department of Medicine, Hematology and Clinical Immunology Branch, Padua, Italy. ^[1] Venetian Institute of Molecular Medicine (VIMM), Padua, Italy. ^[2] Department of Clinical Hematology, University Hospital of Rennes, Rennes, France. ^[3] Biology Department, University Hospital of Rennes, Rennes, France. ^[4]

关键词 STAT3 mutation fas ligand immunophenotype large granular lymphocyte leukemia neutropenia

DOI 10.18632/oncotarget.18711

PMID 28977911

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交